Medical Research

NEUROBIOLOGY FOUNDATION INC

Alpharetta, GA

Mission

We maintain efficient and effective organizational strategies in raising funds and providing grants to individual scientists and physicians for advanced research in molecular and neuropathological abnormalities of schizophrenia and bipolar disorder. We are focused on the development of improved management or cure of these diseases, and in generating an invaluable body of peer-reviewed literature and technological innovation.

Ruling Year

2012

Executive Director

Dr. Jeremy D. Ollerenshaw

Main Address

420 Water Shadow Ln

Alpharetta, GA 30022 USA

Keywords

Schizophrenia, Bipolar Disorder, Research, Mental Illness

EIN

45-3952174

 Number

0226473576

Cause Area (NTEE Code)

Neurology, Neuroscience (H96)

IRS Filing Requirement

This organization is required to file an IRS Form 990-N.

Social Media

Blog

Programs + Results

What we aim to solve New!

Add a problem overview to your profile.

Update now

Our programs

What are the organization's current programs, how do they measure success, and who do the programs serve?

SOURCE: Self-reported by organization

Scientific and Clinical Research Program

Where we workNew!

Add a map of your service areas to your profile.

Update now

Charting Impact

Five powerful questions that require reflection about what really matters - results.

SOURCE: Self-reported by organization

What is the organization aiming to accomplish?

What are the organization's key strategies for making this happen?

What are the organization's capabilities for doing this?

How will they know if they are making progress?

What have and haven't they accomplished so far?

The NeuroBiology Foundation is focused on clearly understanding the molecular and neuropathological abnormalities of schizophrenia and bipolar disorder to reveal precise therapeutic targets upon which effective and well tolerated pharmacological strategies can be base. This is achieved by providing grants to individual scientists and physicians for highly focused research. We will also build strong relationships with our donors, clinical research scientists and the broader research community, patient advocacy groups and other foundations working to advance care and treatment options in serious mental illness.

We strongly believe in our research potential in being able to cure or reveal new therapeutic targets through research and subsequent translational studies to enable the development of better-tollerated and effective therapeutics in these illnesses to improve the lives of the seriously mentally ill, and those of their families and friends.

The NeuroBiology Foundation has specific strategies to achieve its goals and these have been tailored for the differing communities with which it works.

For Researchers-the Foundation will provide access to: (a) Drug and clinical trial databases, (b) subject matter experts, (c) validated therapeutic targets, (d) validated biomarkers, (e) validated preclinical models and provide research grant funding for: (a) scientific programs, (b) translational programs, (c) patient registries, (d) clinical studies.

For Clinicians-the Foundation will facilitate: (a) optimization of therapeutic protocols for new or existing therapeutics, (b) advanced treatment options, (c) examination the outcomes of poor medication compliance and mitigation of risks to patients, (d) physician education in early diagnosis and intervention, communication with patients about their illness and treatment options.
Engage clinicians in clinical research:

For Patients-the Foundation will educate on: (a) better therapeutic options, (b) increased therapeutic compliance rates, (c) better management of mental illness to prevent illness progression, (d) improved communication with their physicians, (e) managing the effects of stigma, (f) facilitate a productive role in the workforce, (g) prevention of entry into judicial system or the homeless population and (e) reduction in the number of suicides.

For Economics-the Foundation will, through research and development of better therapeutics: (a) improve treatment of those suffering with schizophrenia and bipolar disorder, (b) maintain a more healthy workforce, (c) reduce the economic impact of severe mental illness worldwide, (d) reduce the number of people with severe mental illness that are homeless or in our prisons and jails.

The NeuroBiology Foundation is founded by a research scientist in biotechnology with a 30-year professional career in the health care industry with over 50 peer-reviewed publications in the international scientific literature, and a commitment to translational and clinical research in schizophrenia and bipolar disorder of the highest integrity. In addition, the Organization is governed by a Board of Directors with significant track-record in academic, foundation and corporate scientific research specific to mental illness and the areas of interest to the neurobiology of schizophrenia and bipolar disorder. Also, the Board has sufficient expertise gained over decades of performance in foundation and corporate organizations in marketing, market research, grant and technical writing and fundraising to successfully accomplish its goals.

The NeuroBiology Foundation is privileged to have a scientific advisory board comprising 10 of the most prestigious clinical and academic scientists and psychiatrists in the USA. This group of doctors have been pivotal in crafting our strategy to address schizophrenia and bipolar disorder and they continue to be available to the Organization for consult and networking with other scientists and clinicians across the globe.

The NeuroBiology Foundation is committed to making rapid and significant progress towards a cure and better treatment options for schizophrenia and bipolar disorder. Key outcome measures of our strategy would be in (a) translational clinical and scientific publications in these serious mental illnesses, (b) positive outcomes in clinical trials of new treatment options or entities (c) partnerships with the pharmaceutical and/or medical device industry in developing new treatment options, (d) reductions in the number of untreated cases of schizophrenia and bipolar disorder, (e) the reduction of the prison population, (f) the reduction of the homeless population, (g) a significant reduction in the economic burden of mental illness in the United States, and (h) the significant decrease in the rate of suicides.

The NeuroBiology Foundation has places significant emphasis on development of a strategic focus based on a rigorous review of reports, literature and broadly other organizational strategies regarding severe mental illness and its social and economic impact. The Organization is now poised to implement it's highly focused strategy in the USA, and is engaged in raising the funds necessary for a five-year program of research to cure and develop new treatment options in schizophrenia and bipolar disorder that will help millions of people across the world.

External Reviews

Financials

Need more info on this nonprofit?

Need more info on this nonprofit?

FREE: Gain immediate access to the following:

  • Address, phone, website and contact information

Operations

The people, governance practices, and partners that make the organization tick.

Need more info?

FREE: Gain immediate access to the following:

  • Address, phone, website and contact information

Board Leadership Practices

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section, which enables organizations and donors to transparently share information about essential board leadership practices.

SOURCE: Self-reported by organization

BOARD ORIENTATION & EDUCATION

Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations?

Not Applicable

CEO OVERSIGHT

Has the board conducted a formal, written assessment of the chief executive within the past year?

Not Applicable

ETHICS & TRANSPARENCY

Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year?

Not Applicable

BOARD COMPOSITION

Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership?

Not Applicable

BOARD PERFORMANCE

Has the board conducted a formal, written self-assessment of its performance within the past three years?

Not Applicable